(Q51389843)

English

Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis.

scientific article published in February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Chi Chiu Mok

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

Gary Tin Choi Ko

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

Ling Yin Ho

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

Ka Lung Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

Pak To Chan

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

Chi Hung To

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

Arthritis Care and Research

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

63

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

195-202

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

High prevalence of metabolic syndrome in patients with ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Long-term effects of tumor necrosis factor-alpha treatment on insulin signaling pathway in HepG2 cells and HepG2 cells overexpressing constitutively active Akt/PKB.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Interleukin-6 induces cellular insulin resistance in hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Extreme insulin resistance of the central adipose depot in vivo

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Triglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-α blockade

1 reference

https://api.crossref.org/works/10.1002%2FACR.20363

21 January 2018

Identifiers

10.1002/ACR.20363

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20890981

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51389843&oldid=1250825749"